Evidence map›Paper›PMID 40573998›Full record

ArticlePharmaceutics2025

Process Analytical Strategies for Size Monitoring: Offline, At-Line, Online, and Inline Methods in a Top-Down Nano-Manufacturing Line.

Christina Glader, Ramona Jeitler, Yan Wang, Remy van Tuijn, Albert Grau-Carbonell, Carolin Tetyczka, Steve Mesite, Philippe Caisse, Johannes Khinast, Eva Roblegg

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christina GladerResearch Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.
Ramona JeitlerInstitute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, University of Graz, Universitätsplatz 1, 8010 Graz, Austria.ORCID 0000-0002-8414-1761
Yan WangInProcess-LSP, Kloosterstraat 9, 5349 AB Oss, The Netherlands.
Remy van TuijnInProcess-LSP, Kloosterstraat 9, 5349 AB Oss, The Netherlands.
Albert Grau-CarbonellInProcess-LSP, Kloosterstraat 9, 5349 AB Oss, The Netherlands.ORCID 0000-0002-8901-389X
Carolin TetyczkaResearch Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.
Steve MesiteMicrofluidics International Corporation, 90 Glacier Drive, Westwood, MA 02090, USA.
Philippe CaisseGattefossé SAS, 36 chemin de Genas, 69800 Saint-Priest, France.ORCID 0009-0004-3245-7483
Johannes KhinastResearch Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.
Eva RobleggInstitute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, University of Graz, Universitätsplatz 1, 8010 Graz, Austria.ORCID 0000-0002-5553-5147

Funding

Austrian Research Promotion AgencyBundesministerium für Klimaschutz, Umwelt, Energie, Mobilität, Innovation und TechnologieSteirische Wirtschaftsförderung
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

continuous top-down manufacturingdynamic light scatteringlipid-based nanosystemsPAT toolsreal-time size monitoringspatially resolved dynamic light scattering

Identifiers

PMID40573998
PMCPMC12196105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.